PharmaCyte Share Price

PharmaCyte Share Price

NASDAQ: PMCB | Micro Cap | Healthcare
$4.00
-$0.82 (-17.01%) Last updated on 21 Nov, 2026 | 02:26 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

PharmaCyte Stock Performance

Open
N/A
Prev. Close
$4.82
Circuit Range
N/A
Day Range
N/A
Year Range
$0.30 - $7.13
Volume
N/A
Average Traded
N/A

PharmaCyte Share Price Chart

Line chart of the PharmaCyte price trend over the selected period. The price fell overall, ranging from 4.00 to 4.21, ending at 4.00.
$0.00$0.00
L
Show Current Price
H

PharmaCyte Stock Fundamentals & Key Indicators

Market Cap
$29.32M
PE Ratio (TTM)
N/A
Dividend Yield
14.65%
EPS (TTM)
$-63.57
Revenue (TTM)
$0.00
Return On Equity (TTM)
-130.58%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
31.24%

PharmaCyte Quarterly Profit & Loss

All figures in USD

ParticularsOct 2025Jan 2026Apr 2026Jul 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.42-$1.56-$20.16-$5.79
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A81.47%-1192.31%71.28%

PharmaCyte Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.32-$17.24$23.36-$23.21
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-299.07%235.50%-199.36%

PharmaCyte Balance Sheet

All figures in USD Million

Particulars2026202520242023
Non Current Assets9.3332.799.465.13
Current Assets37.4222.3850.4468.15
Total Assets46.7555.1759.973.28
Non Current Liabilities10.950.3612.970.0
Current Liabilities0.832.917.420.59
Total Liabilities11.773.2820.390.59
Shareholders' Equity33.2951.8939.5172.69

PharmaCyte Cash Flow

Annually

All figures in USD Million

Particulars2026202520242023
Operating-5.15-2.98-2.15-3.79
Investing2.0-7.0-5.00.0
Financing6.58-25.03-10.71-13.56

Corporate Actions

Split
Ex-date: 13 Nov 2026

Split
Ex-date: 12 Jul 2021

About PharmaCyte

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

PharmaCyte Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.31
$4.00
+1,211.48%
Oct 2026
$0.40
$0.30
-30.21%
Sep 2026
$0.49
$0.44
-18.92%
Aug 2026
$0.57
$0.54
-5.44%
Jul 2026
$0.76
$0.57
-25.97%
Jun 2026
$0.81
$0.77
-5.87%
May 2026
$0.74
$0.82
+7.77%
Apr 2026
$0.71
$0.76
+15.00%
Mar 2026
$0.70
$0.66
-6.91%
Feb 2026
$0.80
$0.71
-12.68%
Jan 2026
$0.70
$0.81
+13.88%
Dec 2025
$0.75
$0.71
-7.40%

PharmaCyte Share Price FAQs